§ Paul FlynnTo ask the Secretary of State for Health if he will extend the yellow card reporting scheme to allow narrative testimonies from patients. [158529]
§ Miss Melanie JohnsonThe Medicines and Healthcare Products Regulatory Agency (MHRA) is piloting a scheme to allow patients to report suspected adverse drug reaction via NHS Direct. Patients in the catchment area of the South East London NHS Direct site are currently able to contact NHS Direct to report suspected adverse drug reactions, and the scheme is to be extended to other NHS Direct sites in due course.
1620WFollowing an increase in the number of requests for access to Yellow Card data, an independent review is being undertaken by Dr. Jeremy Metters. The steering committee, set up to assist the review, has consulted widely with key stakeholders. The review is considering whether there can be improved involvement of patients in the scheme, which may include enabling patients to report suspected adverse drug reactions to the MHRA directly. The results of the review are expected to be published later this year.